A serum Biomarker model to diagnose pancreatic cancer using proteomic fingerprint technology

Wray CJ, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005; 128: 1626–1641.

Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet 2004; 363: 1049–1057.

Hawes RH, Xiong Q, Waxman I, et al. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 2000; 95: 17–31.

Ishikawa O, Ohigashi H, Imaoka S, et al. Minute carcinoma of the pancreas measuring 1 cm or less in diameter-collective review of Japanese case reports. Hepatogastroenterology 1999; 46: 8–15.

Nakao A, Fujii T, Sugimoto H, et al. Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006; 12: 4466–4472.

Kalra MK, Maher MM, Mueller PR, et al. State-of-theart imaging of pancreatic neoplasms. Br J Radiol. 2003; 76: 857–865.

Carpelan-Holmström M, Louhimo J, Stenman UH, et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002; 22: 2311–2316.

Zhao XY, Yu SY, Da SP, et al. A clinical evaluation of serological diagnosis for pancreatic cancer. World J Gastroenterol. 1998; 4:147–149.

Kim JE, Lee KT, Lee JK, et al. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 2004; 19: 182–186.

Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411: 375–379.

Hanash SM. Global profiling of gene expression in cancer using genomics and proteomics. Curr Opin Mol Ther 2001; 3: 538–545.

Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature 2003; 425:905.

Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21:1164–1177.

Zhu H, Snyder M. Protein chip technology. Curr Opin Chem Biol 2003; 7: 55–63.

Issaq HJ, Veenstra TD, Conrads TP, et al. The SELDITOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Comm 2002; 292:587–592.

Conrads TP, Hood BL, Issaq HJ, et al. Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Mol Diagn 2004; 8:77–85.

Petricoin EF, Liotta LA. SELDI-TOF-MS based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 2004; 15: 24–30.

Petricoin EF 3rd, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94: 1576–1578.

Bañez LL, Prasanna P, Sun L, et al. Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 2003; 170: 442–446.

Malik G, Ward MD, Gupta SK, et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 2005; 11: 1073–1085.

Somiari RI, Somiari S, Russell S, et al. Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815: 215–225.

Langbein S, Lehmann J, Harder A, et al. Protein profi ling of bladder cancer using the 2D-PAGE and SELDITOF-MS technique. Technol Cancer Res Treat 2006; 5: 67–72.

Paradis V, Degos F, Dargère D, et al. Identifi cation of a new marker of hepatocellular carcinoma by serum protein profi ling of patients with chronic liver diseases. Hepatology 2005; 41: 40–47.

Kozak KR, Amneus MW, Pusey SM, et al. Identification of biomarkers for ovarian cancer using strong anionexchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A 2003; 100: 12343–12348.

Rosty C, Goggins M. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach. Methods Mol Med 2005; 103: 189–197.

Bhattacharyya S, Siegel ER, Petersen GM, et al. Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia 2004; 6: 674–686.

Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004; 10: 860–868.

Honda K, Hayashida Y, Umaki T, et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 2005; 65: 10613–10622.

Ehmann M, Felix K, Hartmann D, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profi ling. Pancreas 2007; 34: 205–214.

Srinivas PR, Verma M, Zhao Y, et al. Proteomics for cancer biomarker discovery. Clin Chem 2002; 48: 1160–1169.

Hanash S. Disease proteomics. Nature 2003; 422: 226–232.

Rodland KD. Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin Biochem 2004; 37: 579–583.